What is the recommended starting dose and titration schedule of fluvoxamine for obsessive‑compulsive disorder?

How to Start and Titrate Fluvoxamine for OCD

Start fluvoxamine at 50 mg once daily at bedtime in adults, then increase by 50 mg increments every 4-7 days as tolerated, targeting a therapeutic range of 100-300 mg/day (maximum 300 mg/day), with doses above 100 mg split into two divided doses (larger dose at bedtime). 1

Starting Dose

Adults

• Initial dose: 50 mg at bedtime as a single daily dose 1
• This lower starting dose helps minimize initial gastrointestinal side effects and improves tolerability

Pediatric Patients (Ages 8-17)

• Initial dose: 25 mg at bedtime as a single daily dose 1
• Maximum dose varies by age:
  • Children up to age 11: 200 mg/day maximum
  • Adolescents: Up to 300 mg/day (adult maximum dose)
• Female children may achieve therapeutic effect at lower doses 1

Special Populations

• Elderly or hepatically impaired patients: Use lower initial doses and slower titration due to decreased drug clearance 1

Titration Schedule

Increase by 50 mg increments every 4-7 days as tolerated until maximum therapeutic benefit is achieved 1. In pediatric patients, use 25 mg increments every 4-7 days 1.

Dosing Strategy

• Once total daily dose exceeds 100 mg (or 50 mg in pediatrics), split into two divided doses
• Give the larger dose at bedtime if doses are unequal 1
• Target therapeutic range: 100-300 mg/day based on controlled trials 1

Key Clinical Considerations

Higher Doses Are Often Necessary

OCD requires higher SSRI doses than depression or other anxiety disorders 2. The evidence shows fluvoxamine was studied in the 100-300 mg/day range for OCD 1, and higher doses are associated with greater efficacy, though also higher dropout rates due to adverse effects 2.

Time to Response

• Guidelines recommend 8-12 weeks to determine full efficacy 2
• However, significant improvement can be observed within the first 2 weeks, with greatest incremental gains occurring early in treatment 2
• Early reduction by 4 weeks predicts treatment response at 12 weeks 2

Maintenance Duration

• Continue for a minimum of 12-24 months after achieving remission 2
• Many patients require longer treatment due to high relapse risk after discontinuation 2
• OCD is a chronic condition warranting extended treatment in responders 1

Common Pitfalls to Avoid

1. Underdosing: Don't stop at 50 mg—most patients need 100-300 mg/day for OCD
2. Premature discontinuation: Wait the full 8-12 weeks before declaring treatment failure
3. Abrupt cessation: Always taper gradually to avoid discontinuation symptoms 1
4. Ignoring adverse effects: Nausea is the most common side effect; careful monitoring of GI symptoms and sexual dysfunction is crucial 2

Treatment Resistance

Approximately 50% of patients fail to fully respond to first-line SSRI treatment 2. If inadequate response after an adequate trial:

• Consider switching to a different SSRI
• Trial doses higher than the maximum recommended (with careful monitoring)
• Add CBT if available (most effective augmentation strategy) 2
• Consider pharmacological augmentation with antipsychotics or clomipramine 2

Efficacy Evidence

Fluvoxamine demonstrates response rates of 38-52% in OCD compared to 0-18% with placebo 3. It shows similar efficacy to clomipramine but with superior tolerability, particularly fewer anticholinergic and cardiovascular effects 4, 5. This supports its use as a first-line agent alongside other SSRIs 2.